(Q33475998)

27 July 2017

Phase II trial of tamoxifen in metastatic carcinoma of the prostate (English)

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

27 July 2017

phase II clinical trial

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

1 reference

4

Negendank W

1 reference

27 July 2017

J. H. Glick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6174204

20 August 2023

A. Wein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6174204

20 August 2023

K. Padavic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6174204

20 August 2023

D. Harris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6174204

20 August 2023

H. Brodovsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6174204

20 August 2023

language of work or name

English

0 references

publication date

1 April 1982

1 reference

full work available at URL

27 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

1 reference

27 July 2017

49

1 reference

27 July 2017

7

1 reference

27 July 2017

1367-1372

1 reference

Hormonal therapy of breast cancer: new approaches and concepts

27 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819820401%2949%3A7%3C1367%3A%3AAID-CNCR2820490711%3E3.0.CO%3B2-8

Letter: Antiestrogens in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819820401%2949%3A7%3C1367%3A%3AAID-CNCR2820490711%3E3.0.CO%3B2-8

Orchiectomy for advanced prostatic carcinoma A reevaluation

21 January 2018

1

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Adrenalectomy and hypophysectomy for prostatic cancer

20 August 2023

2

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

20 August 2023

4

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Steroid receptor content in human prostatic carcinoma and response to endocrine therapy

20 August 2023

5

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

Cancer Treatment Reports

6

64

813

Glick

1980

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial

20 August 2023

7

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Steroid receptors in the human prostate. 2. Some properties of the estrophilic molecule of benign prostatic hypertrophy

20 August 2023

8

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer

20 August 2023

9

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

Cancer Treatment Reports

11

61

317

Johnson

1977

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Tamoxifen (antiestrogen) therapy in advanced breast cancer

20 August 2023

12

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases

20 August 2023

17

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Chemotherapy of advanced prostatic cancer. Evaluation of response parameters

20 August 2023

18

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)

20 August 2023

19

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

20

26

381a

Tisman

1976

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II

20 August 2023

22

1 reference

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19820401)49:7%3C1367::AID-CNCR2820490711%3E3.0.CO;2-8

20 August 2023

Identifiers

10.1002/1097-0142(19820401)49:7<1367::AID-CNCR2820490711>3.0.CO;2-8

1 reference

27 July 2017

1 reference